Fifty years of progress in gastric cancer Review


Authors: Coit, D. G.; Strong, V. E.
Review Title: Fifty years of progress in gastric cancer
Abstract: As with every human malignancy, the diagnosis, staging, and treatment of patients with gastric cancer have undergone enormous evidence-based change over the last 50 years, largely as a result of increasingly rapid developments in technology and science. Some of the changes in clinical practice have derived from prospective randomized controlled trials (RCTs), whereas others have come from study of meticulously maintained prospective databases, which define the disease's natural history over time, and occasionally from in-depth analysis of a single patient with an unexpectedly good or poor outcome. Herein we summarize the more important changes in gastric cancer management and the data supporting those changes. © 2022 Wiley Periodicals LLC.
Keywords: cancer surgery; cancer adjuvant therapy; cancer staging; antineoplastic agent; cancer diagnosis; lymph node dissection; randomized controlled trials as topic; pathology; diagnostic imaging; cancer therapy; gastrectomy; stomach cancer; minimally invasive surgery; stomach neoplasms; stomach tumor; gastric cancer; surgical margin; randomized controlled trial (topic); surgical oncology; humans; human; article; cancer management
Journal Title: Journal of Surgical Oncology
Volume: 126
Issue: 5
ISSN: 0022-4790
Publisher: Wiley Blackwell  
Date Published: 2022-10-01
Start Page: 865
End Page: 871
Language: English
DOI: 10.1002/jso.27060
PUBMED: 36087088
PROVIDER: scopus
PMCID: PMC9469502
DOI/URL:
Notes: Article -- Export Date: 3 October 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vivian Strong
    264 Strong
  2. Daniel Coit
    542 Coit